๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prostate Cancer Chemoprevention Agent Development: The National Cancer Institute, Division of Cancer Prevention Portfolio

โœ Scribed by PARNES, HOWARD L.; HOUSE, MARGARET G.; KAGAN, JACOB; KAUSAL, DAVID J.; LIEBERMAN, RONALD

Book ID
121949248
Publisher
Lippincott Williams and Wilkins
Year
2004
Tongue
English
Weight
80 KB
Volume
171
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Chemoprevention of prostate cancer: The
Chemoprevention of prostate cancer: The prostate cancer prevention trial
โœ Thompson, Ian M.; Coltman, Charles A.; Crowley, John ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 67 KB ๐Ÿ‘ 2 views

## BACKGROUND. A variety of innovative approaches to the prevention of prostate cancer are now available, including selenium, alpha tocopherol, dietary interventions, and vitamin D. Perhaps the most promising opportunity is based upon considerable evidence that cumulative androgen exposure of the

Introductory remarks: Development of che
Introductory remarks: Development of chemopreventive agents for prostate cancer
โœ Gary J. Kelloff; Charles W. Boone; Winfred F. Malone; Vernon E. Steele; Linda A. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 699 KB

The term "cancer chemoprevention" refers to the prevention of cancer by intervening with drugs prior to the malignant ( k . , invasive) stage of carcinogenesis. The development of chemopreventive drugs is the major objective of the Chemoprevention Branch at the National Cancer Institute. The testin